TrialInternational journal of clinical oncology2021

Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.

Tsukasa Hasegawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.